Zai Lab partners with Amgen for combination cancer therapy trial
Go back to Zai Lab partners with Amgen for combination cancer therapy trial| Amgen Inc (NASDAQ: AMGN) | Delayed: 366.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.05 | 52 Week High | $176.85 | |||
| Open | $366.05 | 52 Week Low | $133.64 | |||
| Day High | $366.05 | P/E | 55.13 | |||
| Day Low | $366.05 | EPS | $6.64 | |||
| Volume | 641 | |||||
| (NASDAQ: ZLAB) | Delayed: 20.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.50 | 52 Week High | $ | |||
| Open | $20.50 | 52 Week Low | $ | |||
| Day High | $20.50 | P/E | N/A | |||
| Day Low | $20.50 | EPS | $ | |||
| Volume | 11,232 | |||||
